Clinical trial
Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin
NCT00635050
Study timeline
Study start (unknown)2008-03-01Date precision: month
Registry last updated2016-07-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Invasive Breast Cancerunresolved
Interventions
Sponsors & collaborators
University of Alabama at Birminghamlead sponsor
Ortho Biotech, Inc.collaborator
Genentech, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00635050 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.